v3.26.1
Commitments and Contingencies - Additional Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 23, 2022
USD ($)
Jun. 15, 2022
USD ($)
Nov. 09, 2021
USD ($)
Apr. 10, 2019
USD ($)
Jun. 06, 2018
USD ($)
Jun. 30, 2026
USD ($)
obligation
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
obligation
Jun. 30, 2025
USD ($)
Nov. 05, 2020
obligation
Type of Arrangement [Abstract]                    
Payments for CVR           $ 0   $ 0    
Number of milestones accrued | obligation           0   0    
Number of potential milestones | obligation           0   0    
Rent expense           $ 100 $ 100 $ 200 $ 200  
Rexahn                    
Type of Arrangement [Abstract]                    
Number of contingent value right received per common stock | obligation                   1
LCA5/RDH12 Agreement | Development, Regulatory and Commercial Milestone | Maximum                    
Type of Arrangement [Abstract]                    
Milestone payments   $ 2,600                
Iveric Agreement | Commercial Milestones | Maximum | BEST1 Program                    
Type of Arrangement [Abstract]                    
Milestone payments $ 111,700                  
BEST1 License Agreement | Commercial Milestones | Maximum | First Licensed Product                    
Type of Arrangement [Abstract]                    
Milestone payments       $ 76,400            
Penn and UF RHO License Agreement | Development, Regulatory and Commercial Milestone | Maximum                    
Type of Arrangement [Abstract]                    
Milestone payments         $ 93,500          
Massachusetts Eye and Ear Infirmary License Agreement | Development, Regulatory and Commercial Milestone | Maximum                    
Type of Arrangement [Abstract]                    
Milestone payments     $ 400